by sfrazee | Dec 23, 2022
This Policy Brief analyzes the impact of The Inflation Reduction Act (IRA) on generic and biosimilar competition. We first review the large savings that generic and biosimilar competition entails in the U.S., which is threatened by competitors’ uncertain investments....